For more information or confidential assistance
Call 800-306-3180

Laura Woods

Laura Woods is committed to patient safety issues. She enjoys breaking news about FDA recalls, sharing important events in pharmaceutical litigation, and reporting on favorable outcomes for victims of dangerous drugs and medical devices.

EMA Issues New Guidelines for Invokana

On February 12, the European Medicines Agency issued a new set of recommendations to minimize the risk of diabetic ketoacidosis in patients taking SGLT2 inhibitors — including Invokana. SGLT2 inhibitors are a type of type 2 diabetes medication designed to help lower blood sugar in... Read More